The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Agenus
Phase 1/2 open-label, multiple ascending dose trial of AGEN2034, an anti-PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation.
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Oncology (Inst); TESARO (Inst); VBL Therapeutics (Inst)
Research Funding - Lilly (Inst); PTC Therapeutics (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Charles Dresher
No Relationships to Disclose
 
Joyce Liu
Consulting or Advisory Role - AstraZeneca; Tesaro
Research Funding - Acetylon Pharmaceuticals (Inst); Agenus (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Merrimack (Inst)
 
David M. O'Malley
Honoraria - Clovis Oncology
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Clovis Oncology; Janssen Oncology; Myriad Genetics; Novocure; Tesaro
Research Funding - Agenus (Inst); Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Immunogen (Inst); Janssen Research & Development (Inst); PharmaMar (Inst); Regeneron (Inst); Stem CentRx (Inst); Tesaro (Inst); TRACON Pharma (Inst); VentiRx (Inst)
 
Edward Wenge Wang
No Relationships to Disclose
 
Judy Sing-Zan Wang
Speakers' Bureau - AstraZeneca/MedImmune
 
Vivek Subbiah
Consulting or Advisory Role - MedImmune
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; PharmaMar
 
Breelyn A. Wilky
Consulting or Advisory Role - Janssen Oncology; Lilly; Novartis
Research Funding - Agenus; ArQule; Daiichi Sankyo; Merck Sharp & Dohme; Novartis
Travel, Accommodations, Expenses - Advenchen Laboratories; Lilly; Novartis
 
Guojun Yuan
Employment - Agenus
 
Christopher D Dupont
Employment - Agenus; Rochester Eye Associates (I); Vertex (I)
Stock and Other Ownership Interests - Agenus; Vertex (I)
Research Funding - Agenus; Pfizer; Sanofi; Vertex (I)
Travel, Accommodations, Expenses - Agenus
 
Ana M Gonzalez
Employment - Agenus
Stock and Other Ownership Interests - Agenus
 
David Savitsky
Employment - Agenus
 
Sara Coulter
Employment - Agenus
 
Olga Shebanova
Employment - Agenus
Stock and Other Ownership Interests - Agenus
Travel, Accommodations, Expenses - Agenus
 
Ed Dow
Employment - Agenus
 
Igor Proscurshim
No Relationships to Disclose
 
Jennifer Buell
Employment - Agenus
Stock and Other Ownership Interests - Agenus
 
Robert Benjamin Stein
Employment - Agenus
Stock and Other Ownership Interests - Agenus
 
Hagop Youssoufian
Employment - Agenus